These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3105853)

  • 1. Effect of cyclooxygenase and thromboxane synthetase inhibition on furosemide-stimulated plasma renin activity.
    Datar S; McCauley FA; Wilson TW
    Can J Physiol Pharmacol; 1987 Jan; 65(1):80-3. PubMed ID: 3105853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Testing the "redirection hypothesis" of prostaglandin metabolism in the kidney.
    Datar S; McCauley FA; Wilson TW
    Prostaglandins; 1987 Feb; 33(2):275-85. PubMed ID: 3296006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced myocardial neutrophil accumulation and infarct size following thromboxane synthetase inhibitor or receptor antagonist.
    Nichols WW; Mehta J; Wargovich TJ; Franzini D; Lawson D
    Angiology; 1989 Mar; 40(3):209-21. PubMed ID: 2537051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of renin by thromboxane: studies with thromboxane synthase inhibitor, receptor antagonists, and mimetic.
    Welch WJ; Wilcox CS; Dunbar KR
    Am J Physiol; 1989 Oct; 257(4 Pt 2):F554-60. PubMed ID: 2508488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of indomethacin on furosemide induced renal prostaglandin synthesis and action in man.
    Kim RB; McCauley FA; Wilson TW
    Clin Invest Med; 1986; 9(3):192-7. PubMed ID: 3530574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beneficial effect of a thromboxane synthetase inhibitor in traumatic shock.
    Hock CE; Lefer AM
    Circ Shock; 1984; 14(3):159-68. PubMed ID: 6542462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beneficial effects of U-63,557A, a thromboxane synthetase inhibitor, in an ovine model of pregnancy-induced hypertension.
    Keith JC; Thatcher CD; Schaub RG
    Am J Obstet Gynecol; 1987 Jul; 157(1):199-203. PubMed ID: 3605254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of selective inhibition of the inducible cyclooxygenase on renin release in healthy volunteers.
    Stichtenoth DO; Wagner B; Frölich JC
    J Investig Med; 1998 Aug; 46(6):290-6. PubMed ID: 9737091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of furegrelate on renal plasma flow after angiotensin II infusion.
    Kaushal RD; Wilson TW
    Can J Physiol Pharmacol; 1990 Apr; 68(4):500-4. PubMed ID: 2328452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thromboxane synthase inhibition enhances furosemide-induced renal vasodilation.
    Wilson TW; Badahman AH; Kaushal RD
    Clin Invest Med; 1993 Oct; 16(5):372-8. PubMed ID: 8261690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diuretic and non-diuretic actions of furosemide: effects of probenecid.
    Walshaw PE; McCauley FA; Wilson TW
    Clin Invest Med; 1992 Feb; 15(1):82-7. PubMed ID: 1572111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of cyclooxygenase metabolite production attenuates ischemia-reperfusion lung injury.
    Ljungman AG; Grum CM; Deeb GM; Bolling SF; Morganroth ML
    Am Rev Respir Dis; 1991 Mar; 143(3):610-7. PubMed ID: 1900402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of thromboxane synthetase potentiates the antihypertensive action of an angiotensin-converting enzyme inhibitor by a prostaglandin-dependent but kinin-independent mechanism.
    Levens NR; Cóte D; Ksander G
    J Pharmacol Exp Ther; 1991 Oct; 259(1):219-27. PubMed ID: 1920118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of experimental cyclosporine nephrotoxicity by inhibition of thromboxane synthesis.
    Petric R; Freeman D; Wallace C; McDonald J; Stiller C; Keown P
    Transplantation; 1990 Oct; 50(4):558-63. PubMed ID: 2219273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective action of a thromboxane synthetase inhibitor in preventing extension of infarct size in acute myocardial infarction.
    Hock CE; Phillips GR; Lefer AM
    Prostaglandins Leukot Med; 1985 Mar; 17(3):339-46. PubMed ID: 3857643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction in myocardial neutrophil accumulation and infarct size following administration of thromboxane inhibitor U-63,557A.
    Wargovich TJ; Mehta J; Nichols WW; Ward MB; Lawson D; Franzini D; Conti CR
    Am Heart J; 1987 Nov; 114(5):1078-85. PubMed ID: 2960223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of specific COX-2-inhibition on renin release and renal and systemic prostanoid synthesis in healthy volunteers.
    Stichtenoth DO; Marhauer V; Tsikas D; Gutzki FM; Frölich JC
    Kidney Int; 2005 Nov; 68(5):2197-207. PubMed ID: 16221219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natriuretic effect of furosemide after inhibition of prostaglandin synthetase.
    Bailie MD; Crosslan K; Hook JB
    J Pharmacol Exp Ther; 1976 Nov; 199(2):469-76. PubMed ID: 824442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of thromboxane A2 synthetase inhibition, singly and combined with thromboxane A2/prostaglandin endoperoxide receptor antagonism, on inositol phospholipid turnover and on 5-HT release by washed human platelets.
    de Chaffoy de Courcelles D; De Clerck F
    Eur J Pharmacol; 1990 Mar; 188(2-3):161-9. PubMed ID: 2318257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased glomerular thromboxane synthesis as a possible cause of proteinuria in experimental nephrosis.
    Remuzzi G; Imberti L; Rossini M; Morelli C; Carminati C; Cattaneo GM; Bertani T
    J Clin Invest; 1985 Jan; 75(1):94-101. PubMed ID: 4038407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.